|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Cardiovascular MRI predicts 5 year adverse clinical outcome in heart transplant recipients
American Journal of Transplantation (login required)
Imaging recommendations for the follow-up of heart transplant recipients lack evidence justifying their prognostic value. Cardiovascular magnetic resonance imaging can characterize heart structure and function and has prognostic value in many myocardial diseases. We hypothesized that CMRI evaluation of cardiac allografts would predict adverse events. We performed CMRI on 60 HTRs evaluating biventricular size, function and myocardial scar. We performed survival analysis to identify independent predictors of cardiovascular death or hospitalization.
Consensus conference on training in HBP surgery
ASTS, along with the Americas Hepato-Pancreato-Biliary Association and the Society of Surgical Oncology, will hold a consensus conference on Training in HBP Surgery Oct. 27, 2014 at the Omni San Francisco.
ASTS history book available
If you weren't able to attend the World Transplant Congress and pick up the book chronicling the past 20 years of ASTS history, you can still get a copy! One free copy is available to ASTS members, and non-members can purchase a copy in the ASTS Store.
Help fund the future!
The ASTS Foundation Fund the Future Campaign has a goal of raising $100,000 to fund research grants. We're halfway there, but we need your help to go all the way! Please consider donating any amount.
UCSF 1st in nation to join with Walgreens in blood pressure testing program for living kidney donors, potential donors
While recipients of living donor kidney transplants receive steady follow-up care, the living donors themselves also need to be monitored. To make follow-up care more accessible, UC San Francisco and Walgreens are collaborating to launch the first program in the country that provides blood pressure testing at no charge to living kidney donors. UCSF will provide vouchers for blood pressure tests redeemable at more than 4,500 Walgreens pharmacies and Healthcare Clinic at select Walgreens locations nationwide.
Through a glass darkly: Seeking clarity in preventing late kidney transplant failure
Journal of the American Society of Nephrology
A common lament is that long-term kidney transplant outcomes remain the same despite improvements in early graft survival. To be fair, progress has been made — in both our understanding of chronic injury and modestly, graft survival. However, we are still a long way from actually solving this important and difficult problem. In this review, we outline recent data supporting the existence of several causes of renal allograft loss, the incidences of which peak at different time points after transplantation.
Management of hepatitis C in kidney transplant patients: On the cusp of change
American Journal of Transplantation
The impact of hepatitis C virus and human immunodeficiency virus infections on the short- and long-term outcomes of kidney transplant recipients have been clouded by the multitude of donor and recipient factors that influence graft and patient survival. In an elegant analysis using the Scientific Registry of Transplant Recipients database, Xia et al removed the donor variables from consideration by comparing outcomes in kidney recipients of paired deceased donor kidneys. In this analysis, the outcomes of the kidney transplanted into a recipient with HCV, HIV or HIV/HCV coinfection was compared to the outcomes of the paired-kidney transplanted into a recipient without these viral infections.
Prior cancer ups death risk after kidney transplantation
Renal & Urology News
A pre-transplant history of malignancy is associated with 22 percent increased risk in 10-year mortality among adult kidney allograft recipients, according to a new study presented at the 2014 World Transplant Congress. However, the researchers found that having a malignancy prior to renal transplantation was not associated with increased risk of death-censored graft loss.
The policy of placing older donors into older recipients: Is it worth the risk?
Clinical Transplantation (login required)
To expand the donor pool, older donors are frequently used in older recipients. Older recipients and those receiving older donor hearts have independently displayed decreased post-transplant survival. However, outcomes in older patients receiving older donor hearts are contentious.
Big data in organ transplantation: Registries and administrative claims
American Journal of Transplantation
The field of organ transplantation benefits from large, comprehensive, transplant-specific national data sets available to researchers. In addition to the widely used Organ Procurement and Transplantation Network-based registries (the United Network for Organ Sharing and Scientific Registry of Transplant Recipients data sets) and United States Renal Data System data sets, there are other publicly available national data sets, not specific to transplantation, which have historically been underutilized in the field of transplantation.
Study: Liver transplants from living donors lead to better survival
By Karen Zabel
For years, research data gathered from nationwide studies provided evidence that liver transplant recipients had an improved chance of survival when they received a liver from a deceased donor compared to a live-donor liver. But a new study from Perelman School of Medicine at the University of Pennsylvania suggests that's just not so. In fact, the researchers report that living-donor transplants can actually offer superior outcomes compared to livers from deceased donors.
Missed our previous issues? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063